ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1617

Evaluating Familiarity and Knowledge Gaps in Polymyalgia Rheumatica Among Public Health Professionals

Erik Stone1, Shilpa Venkatachalam2, angela Degrassi3, Laura Stradford1, Ambika Vartak4 and Shelley Fritz5, 1Global Healthy Living Foundation, Nyack, NY, 2Global Healthy Living Foundation, New York, NY, 3Global Healthy Living Foundation, Upper Nyack, NY, 4Global Healthy Living Foundation, Meriden, 5Global Healthy Living Foundation, Kalaheo, HI

Meeting: ACR Convergence 2025

Keywords: giant cell arteritis, Polymyalgia Rheumatica (PMR), Vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 27, 2025

Title: (1612–1632) Vasculitis – Non-ANCA-Associated & Related Disorders Poster II

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Polymyalgia rheumatica (PMR) is a commonly occurring inflammatory condition affecting older adults, primarily presenting with bilateral shoulder and hip stiffness. Despite its high prevalence in individuals over 50, there is a lack of evidence characterizing awareness or understanding of PMR among public health professionals (PHPs), defined as individuals working in disease diagnosis and treatment, health promotion, disease prevention, and health policy. This study assessed PHPs’ familiarity with PMR and their knowledge across key clinical domains.

Methods: A cross-sectional knowledge assessment was administered to PHPs using convenience sampling via social media platforms and targeted outreach via the American Public Health Association email list. Participants were screened for prior familiarity of polymyalgia rheumatica (PMR) or familiarity with the hallmark symptoms of PMR. Those reporting familiarity were directed to complete a 31-item multiple-choice knowledge assessment across six domains: definition and etiology, epidemiology, diagnosis, treatment, treatment risks and prognosis, and patient satisfaction and reported outcomes. Those with no familiarity were excluded from the assessment to prevent bias but were included in descriptive reporting of awareness levels. Survey items were developed from a systematic literature review and validated by subject matter experts. Descriptive statistics were used to calculate mean scores and domain specific accuracy rates (Figure 1). Only fully completed responses from self-identified PHPs were analyzed. Duplicate entries were removed based on IP address, timestamps, and demographic data.

Results: Of 920 respondents asked about PMR, 289 (31.4%) reported prior awareness, while 631 (68.6%) had not heard of it or were unsure (Table 1). Among those not aware or unsure, 276 (43.7%) recognized a condition with symptoms consistent with PMR. In total, 565 participants familiar with PMR or its symptoms were invited to complete the full knowledge assessment; 417 provided complete responses and were included in the analysis. The average knowledge score was 64.7% (SD: 13.1%), with only 12.2% scoring 80% or higher. The largest knowledge gaps were in epidemiology, which had the lowest average score (30.7%); only 18.2% correctly identified estimated PMR prevalence, and 12.7% knew its estimated annual incidence. In the treatment domain, the mean score was 61.6% with 57.5% not knowing the proportion of patients who continue to experience symptoms with treatment, 50.9% not knowing appropriate visit frequency, and only 44.4% of respondents correctly identifying the first-line treatment for PMR.

Conclusion: Fewer than 40% of PHPs were familiar with PMR by name, and those with prior awareness showed notable gaps in epidemiology and treatment knowledge. Limited understanding of PMR’s prevalence, diagnosis, and management among PHPs may contribute to under-recognition and delayed diagnosis. These findings underscore the need for targeted education to support earlier diagnosis, effective treatment, and better patient outcomes.

Supporting image 1Figure 1: Average Score % (SD) by Survey Domain

Supporting image 2Table 1: PMR Familiarity and Knowledge Assessment Participation Overview


Disclosures: E. Stone: None; S. Venkatachalam: None; a. Degrassi: None; L. Stradford: None; A. Vartak: None; S. Fritz: None.

To cite this abstract in AMA style:

Stone E, Venkatachalam S, Degrassi a, Stradford L, Vartak A, Fritz S. Evaluating Familiarity and Knowledge Gaps in Polymyalgia Rheumatica Among Public Health Professionals [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/evaluating-familiarity-and-knowledge-gaps-in-polymyalgia-rheumatica-among-public-health-professionals/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/evaluating-familiarity-and-knowledge-gaps-in-polymyalgia-rheumatica-among-public-health-professionals/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology